Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

EU court backs neonicotinoids ban
A recent report found that all neonicotinoids pose a threat to many bee species, regardless of how or where they are used in the environment.
Legal action against 2013 ban dismissed 

An EU court has upheld a partial ban on three neonicotinoids that have been linked to declining bee populations.

In 2013, the European Commission placed restrictions on clothianidin, thiamethoxam and imidacloprid, owing to evidence of the threats they pose to bees.

Bayer, which developed clothianidin and imidacloprid, and Syngenta, which developed thiamethoxam, challenged the regulation.

However, the General Court of the European Union said yesterday (17 May) that it upholds the ban and ‘dismisses in their entirety the actions brought by Bayer and Syngenta’.

The ruling states that the commission had correctly applied the ‘precautionary principles’, which allow protective measures to be taken without having to wait until harm occurs, when there is scientific uncertainty about the risks to human health or the environment.

A recent report by the European Food Safety Authority (Efsa) found that all neonicotinoids pose a threat to many bee species, regardless of how or where they are used in the environment.

Last month, a majority of EU member states agreed to ban the outdoor use of clothianidin, thiamethoxam and imidacloprid, limiting their use to crops in greenhouses.

However, the court did annul the measures restricting fipronil, following a challenge brought by chemicals company BASF. The ruling states that the commission breached the precautionary principles by failing to carry out an impact assessment before adopting the restrictions in 2013.

 

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.